Comparison between Alkosign IPO and Vaidya Sane Ayurved Laboratories IPO.
Alkosign IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vaidya Sane Ayurved Laboratories IPO is a SME Fixed Price proposed to list at NSE SME.
| Alkosign IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Shreni Shares Ltd. | First Overseas Capital Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | Bhh Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Alkosign IPO is up to ₹11.53 Cr whereas the issue size of the Vaidya Sane Ayurved Laboratories IPO is up to ₹19.20 Cr. The final issue price of Alkosign IPO is ₹45.00 per share and of Vaidya Sane Ayurved Laboratories IPO is ₹73.00 per share.
| Alkosign IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Final) | ₹45.00 per share | ₹73.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 3000 shares | 1600 shares |
| Fresh Issue Size | 25,62,000 shares | 26,30,400 shares |
| Fresh Issue Size (Amount) | up to ₹11.53 Cr | up to ₹19.20 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 25,62,000 shares | 26,30,400 shares |
| Issue Size Total (Amount) | up to ₹11.53 Cr | up to ₹19.20 Cr |
Alkosign IPO opens on Jan 18, 2022, while Vaidya Sane Ayurved Laboratories IPO opens on Feb 10, 2022. The closing date of Alkosign IPO and Vaidya Sane Ayurved Laboratories IPO is Jan 21, 2022, and Feb 15, 2022, respectively.
| Alkosign IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| Issue Open | Jan 18, 2022 | Feb 10, 2022 |
| Issue Close | Jan 21, 2022 | Feb 15, 2022 |
| Basis Of Allotment (Tentative) | Jan 27, 2022 | Feb 18, 2022 |
| Initiation of Refunds (Tentative) | Jan 28, 2022 | Feb 21, 2022 |
| Credit of Share (Tentative) | Jan 28, 2022 | Feb 22, 2022 |
| Listing date (Tentative) | Feb 01, 2022 | Feb 23, 2022 |
Alkosign IPO P/E ratio is , as compared to Vaidya Sane Ayurved Laboratories IPO P/E ratio of 28.29.
| Alkosign IPO | Vaidya Sane Ayurved Laboratories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100% | 90.08% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 50.41% | 66.34% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 28.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹24.50 Cr. | ₹76.75 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 197 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 30.46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.86 | ₹2.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 98.51 | 15.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Alkosign IPO Retail Individual Investors (RII) are offered 12,81,000 shares while in Vaidya Sane Ayurved Laboratories IPO retail investors are offered 12,81,000 shares. Qualified Institutional Buyers (QIB) are offered in Alkosign IPO and in Vaidya Sane Ayurved Laboratories IPO.
| Alkosign IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| Market Maker Reservation | 1,38,000 shares | 1,40,800 shares |
| NII | 12,81,000 shares | 13,15,200 shares |
| RII | 12,81,000 shares | 13,15,200 shares |
| Total | 25,62,000 shares | 26,30,400 shares |
Alkosign IPO subscribed 4.76x in total, whereas Vaidya Sane Ayurved Laboratories IPO subscribed 2.82x.
| Alkosign IPO | Vaidya Sane Ayurved Laboratories IPO | |
|---|---|---|
| NII (times) | 3.14x | 2.66x |
| RII (times) | 6.39x | 2.98x |
| Total (times) | 4.76x | 2.82x |
